Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Grows By 104.6%

Nihon Kohden Corporation (OTCMKTS:NHNKYGet Free Report) saw a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 8,583 shares, an increase of 104.6% from the May 31st total of 4,196 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 28,647 shares, the days-to-cover ratio is currently 0.3 days.

Analysts Set New Price Targets

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Get Our Latest Stock Analysis on Nihon Kohden

Nihon Kohden Price Performance

OTCMKTS NHNKY remained flat at $8.76 during mid-day trading on Tuesday. 3,564 shares of the company traded hands, compared to its average volume of 27,984. The stock has a market cap of $1.47 billion, a price-to-earnings ratio of 14.84 and a beta of 0.40. Nihon Kohden has a 52-week low of $8.12 and a 52-week high of $14.21. The company has a 50-day moving average price of $9.01 and a two-hundred day moving average price of $10.05.

Nihon Kohden (OTCMKTS:NHNKYGet Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The company had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. As a group, research analysts anticipate that Nihon Kohden will post 0.6 earnings per share for the current year.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

Featured Articles

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.